| Increased alveolar nitric oxide in early systemic sclerosis. | |
MedLine Citation:
|
PMID: 21050538 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVES: Assessment of inflammatory activity in interstitial lung disease of systemic sclerosis (SSc) is difficult. Nitric oxide (NO) has gained attention in the pathogenesis of SSc. The aim of the study was to investigate alveolar NO concentration (CA(NO)) in SSc patients with short disease duration and to relate CA(NO) to radiologic findings. METHODS: In a prospective study, 34 consecutive patients with disease duration of less than 2 years from onset of first non-Raynaud symptom and 26 healthy controls were enrolled. Exhaled NO was measured and CA(NO) was calculated. CA(NO) levels were related to the radiologic extent of pulmonary fibrosis measured as the extent of traction bronchiectasis within areas of ground glass opacities and reticulations. RESULTS: CA(NO) levels were increased in patients with early SSc compared to healthy controls (3.52 (2.94-4.09) versus 2.08 (1.6-2.6); p<0.001). Both SSc patients with SSc-ILD (3.56 (3.04-4.73), p<0.001) and SSc patients without SSc-ILD (2.98 (2.68-3.98), p<0.01) had higher CA(NO) levels compared with healthy controls (2.08 (1.6-2.6)). CA(NO) levels did not differ between SSc patients without SSc-ILD and SSc patients with SSC-ILD. CA(NO) levels did not correlate to the extent of pulmonary fibrosis but were associated with the extent of ground glass opacities (rs=0.37, p<0.05) and reticulations (rs=0.37, p<0.05) on HRCT. CA(NO) levels were not correlated to lung function tests. CONCLUSIONS: In patients with early SSc, alveolar NO is increased and may precede radiological changes of SSc-ILD. CA(NO) may therefore be a marker of early lung involvement. |
Authors:
|
D M Wuttge; G Bozovic; R Hesselstrand; D Aronsson; L Bjermer; A Scheja; E Tufvesson |
Related Documents
:
|
17660708 - The pulmonary involvement in rheumatic diseases: pulmonary effects of ankylosing spondy... 7952658 - Mechanical chest stimulation as a physiotherapy aid. 19819188 - Effects of scoliosis on respiratory muscle strength in patients with neuromuscular diso... 8836648 - Lungs in thalassaemia major patients receiving regular transfusion. 17162718 - Age of seizure onset, functional reorganization, and neuropsychological outcome in temp... 23799558 - Epidemiology, anticoagulant treatment and risk of thromboembolism in patients with valv... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2010-11-03 |
Journal Detail:
|
Title: Clinical and experimental rheumatology Volume: 28 ISSN: 0392-856X ISO Abbreviation: Clin. Exp. Rheumatol. Publication Date: 2010 Sep-Oct |
Date Detail:
|
Created Date: 2010-11-05 Completed Date: 2010-12-21 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8308521 Medline TA: Clin Exp Rheumatol Country: Italy |
Other Details:
|
Languages: eng Pagination: S5-9 Citation Subset: IM |
Affiliation:
|
Department of Clinical Sciences, Lund, Sweden. dirk.wuttge@med.lu.se |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Biological Markers / metabolism Breath Tests Female Humans Male Middle Aged Nitric Oxide / metabolism* Prospective Studies Pulmonary Alveoli / metabolism*, pathology Radiography, Thoracic Respiratory Function Tests Scleroderma, Systemic / metabolism*, pathology, radiography Skin / pathology Time Factors Tomography, X-Ray Computed |
| Chemical | |
Reg. No./Substance:
|
0/Biological Markers; 10102-43-9/Nitric Oxide |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Electronic medical record adoption and use in home health and hospice.
Next Document: Differences in presentation of younger and older systemic sclerosis patients in clinical trials.